0000885590-11-000010.txt : 20110308 0000885590-11-000010.hdr.sgml : 20110308 20110308212859 ACCESSION NUMBER: 0000885590-11-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110304 FILED AS OF DATE: 20110308 DATE AS OF CHANGE: 20110308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Provencio Norma Ann CENTRAL INDEX KEY: 0001343811 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 11673530 MAIL ADDRESS: STREET 1: 1041 WEST BADILLO STEET, SUITE 112 CITY: COVINA, CA STATE: CA ZIP: 91722 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7150 MISSISSAUGA ROAD STREET 2: MISSISSAUGA CITY: ONTARIO STATE: A6 ZIP: 00000 BUSINESS PHONE: 905 286-3000 MAIL ADDRESS: STREET 1: 7150 MISSISSAUGA ROAD STREET 2: MISSISSAUGA CITY: ONTARIO STATE: A6 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2011-03-04 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001343811 Provencio Norma Ann 7150 MISSISSAUGA ROAD MISSISSAUGA A6 L5N 8M5 ONTARIO, CANADA 1 0 0 0 Common Stock, no par value 2011-03-04 4 P 0 1000 39.87 A 117404 D Common Stock, no par value 2011-03-04 4 P 0 195 39.88 A 117599 D Common Stock, no par value 2011-03-04 4 P 0 380 39.88 A 117979 D Deferred Share Units 2011-03-05 4 A 0 2517 0 A Common Stock, no par value 2517 2517 D Common stock held in the reporting person's 401k account. Includes 102,353 Restricted Share Units ("RSUs") held by the reporting person as compensation for her services on the Board of Directors of the issuer, including 3,423 RSUs received as dividend equivalents as a result of a dividend paid on the common stock, no par value, of Valeant Pharmaceuticals International, Inc. on December 22, 2010. Common stock held in the reporting person's IRA. Each Deferred Share Unit entitles its holder, upon ceasing to be a director, to receive an amount of cash having the same value as one share of common sock, no par value of Valeant Pharmaceuticals International, Inc., at such time. /s/ By: Angie Palmer For: Norma Provencio 2011-03-08